Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess
about
The molecular biology, biochemistry, and physiology of human steroidogenesis and its disordersA genetic defect resulting in mild low-renin hypertensionPrenatal excess glucocorticoid exposure and adult affective disorders: a role for serotonergic and catecholamine pathwaysGenetic Approaches to Hypothalamic-Pituitary-Adrenal Axis RegulationReduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasisIn silico structure-function analysis of pathological variation in the HSD11B2 gene sequenceAssociation between umbilical cord glucocorticoids and blood pressure at age 3 years.Children of addicted womenHormonal hypertension in children: 11beta-hydroxylase deficiency and apparent mineralocorticoid excess.Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.Mechanisms of non-genetic inheritance and psychiatric disordersHerbal Medicine Containing Licorice May Be Contraindicated for a Patient with an HSD11B2 Mutation11β-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress.Alteration in methylation level at 11β-hydroxysteroid dehydrogenase type 2 gene promoter in infants born to preeclamptic women.Antenatal dexamethasone treatment leads to changes in gene expression in a murine late placenta.Fetal origins of insulin resistance and obesity.Failure to downregulate the epithelial sodium channel causes salt sensitivity in Hsd11b2 heterozygote mice.Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excessGlucocorticoid "programming" and PTSD risk.Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.Role of the hypothalamic-pituitary-adrenal axis in developmental programming of health and disease.Heritable forms of hypertension.Prenatal stress, glucocorticoids and the programming of adult disease.11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.Monogenic forms of hypertension.Liddle syndrome in a Serbian family and literature review of underlying mutations.Developmental ORIgins of Healthy and Unhealthy AgeiNg: the role of maternal obesity--introduction to DORIAN.Behavioral epigenetics and the developmental origins of child mental health disorders.Association of serum lipid concentrations, insulin resistance index and catch-up growth with serum cortisol/cortisone ratio by liquid chromatography tandem mass spectrometry in children born small for gestational age.Case Report: Application of whole exome sequencing for accurate diagnosis of rare syndromes of mineralocorticoid excess.Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency.Glucocorticoid-induced fetal brain growth restriction is associated with p73 gene activation.
P2860
Q24613957-D93FF4EF-2AA8-494A-A2E7-D3F6C243777CQ24669744-1E18B766-18CC-4E8F-AC6E-E6952AF2EB92Q26825159-010D2B04-0F69-45E3-8738-33E1974ED529Q28082581-7D4AB2E5-FA37-4F6B-A2E4-471488B60191Q28363481-8F6B02A7-E3EE-41CD-BC0A-A67A58BD355EQ30390640-17D22733-56A0-4561-A335-41EB5E5AF30FQ33364551-36044328-A9EA-4D7B-8A9F-E89C7821AAA9Q34111219-DE7CE83D-0426-4A2B-83C7-469999007943Q34128709-E2A4A418-EDAB-45AC-9040-C963E5D040B9Q34206428-EFA6FB91-1CD1-42BC-8D81-4245233DF30CQ34675817-2B2D0719-CFA9-4C8E-837B-2992A4F9F80DQ35106732-7222595D-D2D3-4C5A-A2B5-7E407A779C9DQ35144168-B116CFF4-BBCC-4633-BDEE-6704C8525810Q35189072-5EA4A820-CE01-440B-BE75-A98CAC7BFF3CQ36088980-1ED78E7F-4638-4439-936C-4AE115240765Q36165331-22B67FD7-C0CD-40AC-B39E-9BA7E60B6235Q36192473-BE0FF53D-44D9-4AD2-84A5-98BCC561BB11Q36556877-BED51A9E-93BB-414E-8B64-65A4D72DC03AQ36557730-07822FB7-4199-4878-8A3A-B1EF062A3D9BQ36674845-1C7394C6-D283-4AF7-8BDD-7DDACA4DF09BQ36675080-1CDBFE4D-5B93-404B-880A-651C4555F851Q36890057-12734C8A-1439-4074-8F8A-50FA4FD3B551Q37381156-EEC62F16-C60F-4B9E-9B90-B4B8CC29C141Q37655884-FEE21BFD-BD18-4622-A1E4-7F9BA91B56D4Q37853068-33DABBB5-42CF-4F2F-A040-28F01BE906F2Q37940326-1D44F3F6-1A58-4AA8-88FE-D72E42C25C30Q38209730-0A709A49-FF74-4C36-9ECC-2C5D5F88289DQ38236039-560505D6-1044-4724-8F31-61475D5D75E0Q46691222-E7C74A3D-9983-40BE-9FC1-E626D1309E16Q47153571-34344D57-FF26-4465-9F58-E95905A9D5F7Q47304913-6C31385A-0534-4004-A649-754AC19019D9Q48327105-E0C13DDF-CD19-46CE-9251-6CB338B3A860
P2860
Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Examination of genotype and ph ...... arent mineralocorticoid excess
@ast
Examination of genotype and ph ...... arent mineralocorticoid excess
@en
Examination of genotype and ph ...... arent mineralocorticoid excess
@nl
type
label
Examination of genotype and ph ...... arent mineralocorticoid excess
@ast
Examination of genotype and ph ...... arent mineralocorticoid excess
@en
Examination of genotype and ph ...... arent mineralocorticoid excess
@nl
prefLabel
Examination of genotype and ph ...... arent mineralocorticoid excess
@ast
Examination of genotype and ph ...... arent mineralocorticoid excess
@en
Examination of genotype and ph ...... arent mineralocorticoid excess
@nl
P2093
P356
P1476
Examination of genotype and ph ...... arent mineralocorticoid excess
@en
P2093
C De Santis
C H Shackleton
H I Akkurt
H L Bradlow
J Hertecant
P304
P356
10.1210/JC.83.7.2244
P407
P577
1998-07-01T00:00:00Z